The management of patients with heart failure
is a daily challenge for cardiologists and cardiac surgeons.
Pharmacotherapy, atrio-biventricular resynchronization, myocardial
revascularization, valve repair techniques, latissimus
dorsi cardiomyoplasty, acorn cardiac support device, heart
transplantation and mechanical assist devices do not cover all the needs. The recent progress in cellular and molecular biology
allows the development of new therapies for heart failure.
Transplantation of Autologous Cells: One of the most innovative
consists in the transplantation of autologous ex-vivo expanded
cells into the myocardium for heart muscle regeneration.
This approach is called “cellular cardiomyoplasty”
